Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis.
about
Roles of bioactive sphingolipids in cancer biology and therapeuticsWhere is it and How Does it Get There - Intracellular Localization and Traffic of P-glycoproteinTamoxifen regulation of sphingolipid metabolism--Therapeutic implicationsAlternation in the glycolipid transfer protein expression causes changes in the cellular lipidome.The impact of sphingosine kinase-1 in head and neck cancer.Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Multi-system disorders of glycosphingolipid and ganglioside metabolismGlucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effectP-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.New horizon of MDR1 (P-glycoprotein) study.Sphingolipids in cancer: regulation of pathogenesis and therapy.Lactosylceramide: a lipid second messenger in neuroinflammatory disease.Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.Glycosphingolipid functionsVerotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy.The role of sphingolipids in drug metabolism and transport.Glycosphingolipids: synthesis and functions.Sphingolipid metabolism and interorganellar transport: localization of sphingolipid enzymes and lipid transfer proteins.Hitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death.Synthesis of a novel photoactivatable glucosylceramide cross-linker.Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis.Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons.Graphene nanoribbons elicit cell specific uptake and delivery via activation of epidermal growth factor receptor enhanced by human papillomavirus E5 protein.Glycolipid-Dependent, Protease Sensitive Internalization of Pseudomonas aeruginosa Into Cultured Human Respiratory Epithelial Cells.Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.A novel, promoter-based, target-specific assay identifies 2-deoxy-D-glucose as an inhibitor of globotriaosylceramide biosynthesis.Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer.The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1).
P2860
Q24657499-DB832FA0-A313-467A-8077-52AA7ED2001BQ27008624-F7A7F2D9-0860-4497-8521-1687DB870A23Q28084270-DD19A201-1351-491C-83D9-E500FE925165Q33604530-BEB25D62-17AC-4945-AE30-676F74684E9AQ33649748-E44E03FA-87B0-4D60-97D5-6549D8D98121Q33733991-EDDD4708-C6C5-4E53-8A87-7CA202BF25EFQ33902037-66295878-7F8C-492B-B66B-AE82D2673912Q33991690-F61CA798-2A9B-495C-8729-C74D9E7A49B1Q34407346-B7F2C5F4-43BC-4322-9EC0-EDB140EE2409Q35057879-C0E81B52-F499-461C-8995-90F0187D4875Q36300806-993F52F7-A460-46E9-89D3-95F76C7C6571Q36592826-414977F4-04C9-416D-9EC7-9F514A7114C7Q36994594-680440AA-0646-4B61-AFD2-678C64718F74Q37591813-25EC97CE-DE1E-4B40-BE5D-343FCFA5BABAQ37808219-D56C9EBC-4539-4CF3-AC81-EAD2F3CA4C8DQ37873655-47E3A936-C575-4287-9D54-3FF73156CFFDQ37954271-D38D0B62-D5F2-4CF7-B896-D2382A70BE7DQ38071694-9C9DFC2B-034B-4A4E-8440-D6A1C0B4BC26Q38155963-775D60D3-2E5E-4029-80D3-48DE9ACA4277Q38266425-9FF27B64-6B25-4C4C-A689-3BD0160880DCQ38358175-717D8985-C707-4AFD-834A-CE99FC199B31Q38758310-82467523-7E6F-4533-A26B-617E00117C9CQ38915115-07D6DEE7-4321-4599-BE98-207A9D105DE0Q39421907-9AB7D336-1809-468D-AE0A-CFB7C5C8BF06Q39751424-79E30C1D-0817-4BC9-BAF6-6C73AD208BA6Q40379870-0AA12FD4-5909-49E1-BA91-2EA72C1243B3Q41854202-BA1E5645-ED8A-4FC0-9E89-6DF1B487F159Q42216668-1BDAC055-9CB1-4176-98C6-DFC28D05CD72Q42521464-A649086C-8B95-4E20-BF58-C7639DE13A52Q42811941-DAFCDE32-1768-49EF-9376-EB26284DB7D3Q47110047-438AA15B-5D2E-427C-BB47-B0C9B591F577Q48096434-75FE5BB7-EC7C-4A6B-A2E0-92FD08C41FB7
P2860
Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Role of multiple drug resistan ...... lycosphingolipid biosynthesis.
@en
type
label
Role of multiple drug resistan ...... lycosphingolipid biosynthesis.
@en
prefLabel
Role of multiple drug resistan ...... lycosphingolipid biosynthesis.
@en
P2093
P2860
P356
P1476
Role of multiple drug resistan ...... lycosphingolipid biosynthesis.
@en
P2093
Cameron Ackerley
Clifford Lingwood
Daniel Sillence
María Fabiana De Rosa
P2860
P304
P356
10.1074/JBC.M305645200
P407
P577
2003-12-08T00:00:00Z